Limba
|
Robatumumab (Anti-IGF1R / CD221) is an antibody targeting human IGF-1R (insulin-like growth factor receptor-1). It shows anti-tumor activity and anti-proliferative activity to cancer cells and can be used in osteosarcoma and Ewing sarcoma research. MW :144.6 KD
Price | 16.249,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Robatumumab (Anti-IGF1R / CD221) is an antibody targeting human IGF-1R (insulin-like growth factor receptor-1). It shows anti-tumor activity and anti-proliferative activity to cancer cells and can be used in osteosarcoma and Ewing sarcoma research. MW :144.6 KD |